Analysis of BRCA1 and mtDNA haplotypes and mtDNA polymorphism in familial breast cancer

References

• Alvarez JC, Johnson DL, Lorente JA, Martinez-Espin E, Martinez-Gonzalez LJ, Allard M, Wilson MR, Budowle B. (2007). Characterization of human control region sequences for Spanish individuals in a forensic mtDNA data set. Legal Med (Tokyo, Japan) 9:293–304
   PubMedGoogle Scholar
• Bai RK, Leal SM, Covarrubias D, Liu A, Wong LJ. (2007). Mitochondrial genetic background modifies breast cancer risk. Can Res 67:4687–94
   PubMed Web of Science ®Google Scholar
• Bandelt HJ, Forster P, Sykes BC, Richards MB. (1995). Mitochondrial portraits of human populations using median networks. Genetics 141:743–53
   PubMed Web of Science ®Google Scholar
• Cann RL, Stoneking M, Wilson AC. (1987). Mitochondrial DNA and human evolution. Nature 325:31–6
   PubMed Web of Science ®Google Scholar
• Canter JA, Kallianpur AR, Parl FF, Millikan RC. (2005). Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 65:8028–33
   PubMed Web of Science ®Google Scholar
• Castro MG, Huerta C, Reguero JR, Soto MI, Domenech E, Alvarez V, Gomez-Zaera M, et al. (2006). Mitochondrial DNA haplogroups in Spanish patients with hypertrophic cardiomyopathy. Int J Cardiol 112:202–6
   PubMed Web of Science ®Google Scholar
• Cavalli-Sforza LL, Wilson AC, Cantor CR, Cook-Deegan RM, King MC. (1991). Call for a worldwide survey of human genetic diversity: A vanishing opportunity for the Human Genome Project. Genomics 11:490–1
   PubMed Web of Science ®Google Scholar
• Czarnecka AM, Krawczyk T, Zdrozny M, Lubinski J, Arnold RS, Kukwa W, Scinska A, et al. (2010). Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res Treat 121:511–18
   PubMed Web of Science ®Google Scholar
• Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN. (2007). Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett 249:249–55
   PubMed Web of Science ®Google Scholar
• Eccles DM, Evans DG, Mackay J. (2000). Guidelines for a genetic risk based approach to advising women with a family history of breast cancer. UK Cancer Family Study Group (UKCFSG). J Med Genet 37:203–9
   PubMed Web of Science ®Google Scholar
• Fernandez-Caggiano M, Barallobre-Barreiro J, Rego-Perez I, Crespo-Leiro MG, Paniagua MJ, Grille Z, Blanco FJ, Domenech N. (2012). Mitochondrial haplogroups H and J: Risk and protective factors for ischemic cardiomyopathy. PloS one 7:e44128
   PubMed Web of Science ®Google Scholar
• Freedman ML, Penney KL, Stram DO, Riley S, McKean-Cowdin R, Le Marchand L, Altshuler D, Haiman CA. (2005). A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk. Cancer Res 65:7516–22
   PubMed Web of Science ®Google Scholar
• Frost P, Jugessur A, Apold J, Heimdal K, Aloysius T, Eliassen AK, Fauske L, et al. (2005). Complete mutation screening and haplotype characterization of the BRCA1 gene in 61 familial breast cancer patients from Norway. Dis Mark 21:29–36
   PubMed Web of Science ®Google Scholar
• Hudson G, Carelli V, Spruijt L, Gerards M, Mowbray C, Achilli A, Pyle A, et al. (2007). Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet 81:228–33
   PubMed Web of Science ®Google Scholar
• Ishikawa K, Takenaga K, Akimoto M, Koshikawa N, Yamaguchi A, Imanishi H, Nakada K, et al. (2008). ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science (New York, NY) 320:661–4
   Google Scholar
• Kulawiec M, Owens KM, Singh KK. (2009). Cancer cell mitochondria confer apoptosis resistance and promote metastasis. Cancer Biol Therapy 8:1378–85
   PubMed Web of Science ®Google Scholar
• Lu J, Sharma LK, Bai Y. (2009). Implications of mitochondrial DNA mutations and mitochondrial dysfunction in tumorigenesis. Cell Res 19:802–15
   PubMed Web of Science ®Google Scholar
• Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, et al. (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (New York, NY) 266:66–71
   Google Scholar
• Napierala M, Dere R, Vetcher A, Wells RD. (2004). Structure-dependent recombination hot spot activity of GAA.TTC sequences from intron 1 of the Friedreich's ataxia gene. J Biol Chem 279:6444–54
   PubMed Web of Science ®Google Scholar
• Peto J, Collins N, Barfoot R, Seal S, Warren W, Rahman N, Easton DF, et al. (1999). Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer. J Natl Cancer Inst 91:943–9
   PubMed Web of Science ®Google Scholar
• Pezzotti A, Kraft P, Hankinson SE, Hunter DJ, Buring J, Cox DG. (2009). The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk. PloS one 4:e5356
   Web of Science ®Google Scholar
• Salgado J, Gil C, Robles M, Gutiérrez C, Reyna C, García-Foncillas J. (2008). A characterization of genetic haplotypes in BRCA1 identifies linkage disequilibrium with novel polymorphism in intron 7. Gene Ther Mol Biol 12:175–80
   Google Scholar
• Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, et al. (1997). BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. J Am Med Assoc 278:1242–50
   PubMed Web of Science ®Google Scholar
• Smith TM, Lee MK, Szabo CI, Jerome N, McEuen M, Taylor M, Hood L, King MC. (1996). Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Gen Res 6:1029–49
   PubMed Web of Science ®Google Scholar
• Soares P, Achilli A, Semino O, Davies W, Macaulay V, Bandelt HJ, Torroni A, Richards MB. (2010). The archaeogenetics of Europe. Curr Biol: CB 20:R174–83
   Google Scholar
• Subramanian S, Madgula VM, George R, Mishra RK, Pandit MW, Kumar CS, Singh L. (2003). Triplet repeats in human genome: Distribution and their association with genes and other genomic regions. Bioinformatics (Oxford, England) 19:549–52
   PubMedGoogle Scholar
• Subramanian S, Mishra RK, Singh L. (2003). Genome-wide analysis of Bkm sequences (GATA repeats): Predominant association with sex chromosomes and potential role in higher order chromatin organization and function. Bioinformatics (Oxford, England) 19:681–5
   PubMed Web of Science ®Google Scholar
• van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, Kroner CC, Welsh-Bohmer KA, et al. (2004). Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365:28–32
   PubMed Web of Science ®Google Scholar
• van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, et al. (2003). Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Human Genet 72:804–11
   PubMed Web of Science ®Google Scholar
• Wallace DC. (2012). Mitochondria and cancer. Nature reviews. Cancer 12:685–98
   PubMedGoogle Scholar
• Warburg O. (1930). The metabolism of tumours. London: Constable Co Ltd
   Google Scholar
• Warburg O. (1956). On the origin of cancer cells. Science 123:309–14
   PubMed Web of Science ®Google Scholar
• Wiesbauer M, Meierhofer D, Mayr JA, Sperl W, Paulweber B, Kofler B. (2006). Multiplex primer extension analysis for rapid detection of major European mitochondrial haplogroups. Electrophoresis 27:3864–8
   PubMed Web of Science ®Google Scholar
• Yu M. (2011). Generation, function and diagnostic value of mitochondrial DNA copy number alterations in human cancers. Life Sci 89:65–71
   PubMed Web of Science ®Google Scholar
• Yu M. (2012). Somatic mitochondrial DNA mutations in human cancers. Adv Clin Chem 57:99–138
   PubMed Web of Science ®Google Scholar